Clinical trial
Molecular Imaging of Synaptic Loss in Multiple System Atrophy (MSA)
NCT05121012 is registered in ClinicalTrials.gov with University of Exeter as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Molecular Imaging of Synaptic Loss in Multiple System Atrophy (MSA)
- Lead sponsor
- University of Exeter
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- September 1, 2021
- Completion date
- March 31, 2027
- Enrollment
- 36 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
multiple system atrophy, progressive supranuclear palsy (psp)